Evidence map›Paper›PMID 26673079›Full record

ArticleeLife2015

Catalysis-dependent selenium incorporation and migration in the nitrogenase active site iron-molybdenum cofactor.

Thomas Spatzal, Kathryn A Perez, James B Howard, Douglas C Rees

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 155 citations in OpenAlex.

  1. Article
  2. Molecular basis of NNature communications · 2026
    Article
  3. Review
  4. Article
  5. A Proposed Complete-Cycle Mechanism for Conversion of NChembiochem : a European journal of chemical biology · 2026
    Article
  6. Review
  7. EPR andInorganic chemistry · 2025
    Article
  8. Nature communications · 2025
    Article
  9. Article
  10. The nitrogenase mechanism: new roles for the dangler?Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thomas SpatzalHoward Hughes Medical Institute, California Institute of Technology, Pasadena, United States.
Kathryn A PerezDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States.
James B HowardDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, United States.
Douglas C ReesHoward Hughes Medical Institute, California Institute of Technology, Pasadena, United States.
California Institute of Technology · USHoward Hughes Medical Institute · US

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI REESE, MICHAEL LLOYD · 1985 to 2011
$38.9M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Crystallographic Studies of Electron Tranfer ProteinsR37GM045162 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI REES, DOUGLAS CHARLES · 2003 to 2012
$3.1M
CRYSTALLOGRAPHIC STUDIES OF ELECTRON TRANSFER PROTEINSR01GM045162 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI REES, DOUGLAS CHARLES · 1991 to 2018
$2.2M
Howard Hughes Medical InstituteNCRR NIH HHS P41 RR001209NIGMS NIH HHS GM045162NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM045162NIGMS NIH HHS R37 GM045162
6 · The paper itself

Abstract

Dinitrogen reduction in the biological nitrogen cycle is catalyzed by nitrogenase, a two-component metalloenzyme. Understanding of the transformation of the inert resting state of the active site FeMo-cofactor into an activated state capable of reducing dinitrogen remains elusive. Here we report the catalysis dependent, site-selective incorporation of selenium into the FeMo-cofactor from selenocyanate as a newly identified substrate and inhibitor. The 1.60 Å resolution structure reveals selenium occupying the S2B site of FeMo-cofactor in the Azotobacter vinelandii MoFe-protein, a position that was recently identified as the CO-binding site. The Se2B-labeled enzyme retains substrate reduction activity and marks the starting point for a crystallographic pulse-chase experiment of the active site during turnover. Through a series of crystal structures obtained at resolutions of 1.32-1.66 Å, including the CO-inhibited form of Av1-Se2B, the exchangeability of all three belt-sulfur sites is demonstrated, providing direct insights into unforeseen rearrangements of the metal center during catalysis.

Indexed as

Azotobacter vinelandiiCatalytic DomainCrystallography, X-RayCyanatesModels, MolecularMolybdoferredoxinNitrogenaseProtein ConformationSeleniumSelenium CompoundsCyanatesMolybdoferredoxinNitrogenaseSeleniumSelenium Compoundsselenocyanic acidAzotobacter vinelandiibiochemistrybiophysicsiron sulfur proteinsmetalloproteinsnitrogen fixationstructural biology

Identifiers

PMID26673079
PMCPMC4755756
OpenAlexW2210062196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.